Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.4.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.53NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EU.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.43NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HU.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JB.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.256NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.77NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.34NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.248NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21305.4South Korea
B.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.70NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.43NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.559NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.406NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.69NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
ER.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.640NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
BA.1.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.9 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XUNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.3 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.16.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.372NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.425NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XBB.1.5.55NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HH.8.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FM.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FK.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.7.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.8.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EU.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used